Hospital Ramón y Cajal -ko ikertzaileekin lankidetzan egindako argitalpenak (13)

2002

  1. Risk factors of ischemic heart disease after renal transplantation

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 394-395

1988

  1. Renal effects of fenoldopam in refractory hypertension1

    Journal of Hypertension, Vol. 6, Núm. 8, pp. 665-669

1987

  1. Dopaminergic modulation of aldosterone secretion in the normal menstrual cycle

    Journal of Clinical Hypertension, Vol. 3, Núm. 4, pp. 470-478

  2. Influence of a low sodium diet on the renal response to amino acid infusions in humans

    Kidney International, Vol. 31, Núm. 4, pp. 992-999

1986

  1. Dopamine control of aldosterone secretion in end-stage renal failure

    Revista Espanola de Fisiologia, Vol. 42, Núm. 2, pp. 257-264

1984

  1. Dopaminergic modulation of aldosterone secretion: Effect of sodium balance and postural changes

    Revista Espanola de Fisiologia, Vol. 40, Núm. 1, pp. 63-68

  2. Interference by ranitidine with aldosterone secretion in vivo

    European Journal of Clinical Pharmacology, Vol. 27, Núm. 4, pp. 495-497

1982

  1. The role of urinary PGE2 and renin-angiotensin-aldosterone system in the pathogenesis of essential hypertension

    Clinical and Experimental Hypertension, Vol. A4, Núm. 6, pp. 989-1000